Kapil N Bhalla

25PUBLICATIONS
130CO-AUTHORS
Mechatronics hardware design and architectureHaematological tumoursGene and molecular therapyRegenerative medicine (incl. stem cells)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (25)

|Dec 19, 2025
BET inhibitor-based combinations targeting novel dependencies in MECOM-rearranged (r) AML.

Christine E Birdwell, Warren Fiskus, Christopher P Mill

|Jul 02, 2025
Clonal evolution of hematopoietic stem cells after autologous stem cell transplantation.

Hidetaka Uryu, Koichi Saeki, Hiroshi Haeno

|Apr 16, 2025
A Phase I Study of FHD-286, a Dual BRG1/BRM (SMARCA4/SMARCA2) Inhibitor, in Patients with Advanced Myeloid Malignancies.

Courtney D DiNardo, Amir T Fathi, Ashwin Kishtagari

|Mar 16, 2025
Superior preclinical efficacy of co-treatment with BRG1/BRM and FLT3 inhibitor against AML cells with FLT3 mutations.

Warren Fiskus, Christopher P Mill, Jessica Piel

|Feb 05, 2024
Efficacy of novel agents against cellular models of familial platelet disorder with myeloid malignancy (FPD-MM).

Christopher P Mill, Warren C Fiskus, Courtney D DiNardo

Pageof 5